Catalog No.
PMJ18001
Species reactivity
Mouse
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Mouse IFNLR1 (Thr42-Ala221).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
Cytokine receptor class-II member 12, IFN-lambda-R1, CRF2-12, IFNLR1, IL28RA, IL-28 receptor subunit alpha, Cytokine receptor family 2 member 12, Interleukin-28 receptor subunit alpha, IL-28RA, Interferon lambda receptor 1, IFN-lambda receptor 1, IL-28R-alpha, LICR2, Likely interleukin or cytokine receptor 2
Purification
Purified by antigen affinity column.
Accession
Q8CGK5
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates., PMID:40502981
Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1., PMID:37499093
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity., PMID:36385011
Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects., PMID:34497603
Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals., PMID:33421520
Interferon-λ Receptor Expression: Novel Reporter Mouse Reveals Within- and Cross-Tissue Heterogeneity., PMID:32364818
Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin., PMID:30886417
IFN-λ4 inhibits HIV infection of macrophages through signalling of IFN-λR1/IL-10R2 receptor complex., PMID:30247785
Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells., PMID:26134097
IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production., PMID:25941255
Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells., PMID:23021208
For research use only. Not for human or drug use.
